None (Healthy participants)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Healthy males aged 25 to 49 years - Provided written informed consent after full explanation
Exclusion criteria
Exclusion criteria: History of severe physical illness History of treatments or use of medications that may influence autonomic nervous function Discomfort during hearing tests or when wearing headphones Inability to maintain regular daily routines during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in stress indicators (salivary cortisol concentration, VAS, Jikaku-sho Shirabe, and Emotion and Mood Inventory) before and after the intervention under acute stress conditions. Although the study protocol originally specified autonomic nervous system indicators (e.g., HRV) as the primary outcomes, they could not be analyzed due to data quality issues. Therefore, the above indicators were registered and reported as the primary outcomes. | — |
Countries
Japan
Contacts
POLA Chemical Industries, Inc. Frontier Research Center